Skip to content New The AI buying guide for BD&L executives — now available on demand Watch
News

The Impact Review – Founding Vibe Bio

The Impact Review – Founding Vibe Bio

Article by Hannah Crowe, editor of The Impact Review

Read this article, authored by Hannah Crowe and published by the Impact Review. It discusses how our founder, Alok Tayi’s personal experience with rare disease drove him towards a mission – to fund cures for rare diseases. Out of this mission, Vibe Bio was born.

“In pursuit of a solution, Alok founded a company called Vibe Bio that enables funding for high potential drug programmes, especially in rare diseases. Through a community of patients, scientists, and partners, Vibe Bio’s goal is to identify the most promising candidates for a disease and ensure they receive enough funding to surpass their inflection points.”

Read more…

Co-founder and CEO

Alok has 15 years of experience as a scientist and 12 as a serial entrepreneur. After completing postdoctoral work at Harvard University with George Whitesides, Alok started two pharma SaaS companies, PreScouter and TetraScience, which employ several hundred people combined…